InterVenn

intervenn.com

Inter Venn Biosciences is a life sciences company focused on advancing personalized medicine through its Glyco Vision™ platform, which enables high-resolution glycoproteomic analysis. This innovative platform allows for the discovery of biomarkers that can significantly improve drug development and patient outcomes. By leveraging AI and machine learning, Inter Venn provides insights into glycosylation's role in health and disease, making it a key partner for biopharma organizations and researchers. Founded by notable experts, including a Nobel Laureate, the company is positioned at the forefront of precision medicine, with a robust pipeline of clinical applications aimed at enhancing disease detection and treatment strategies.